Development of electrode sensors for body fluid measurement: Investigation of the possibility of measuring electrical conductivity using blood samples

Investigation of the feasibility of measuring electrical conductivity with paper-based microfluidic chips using blood samples - Investigation of the feasibility of measuring electrical conductivity with paper-based microfluidic chips using blood samples

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052811

Enrollment

Registered

2023-12-01

Start date

2023-12-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Subjects who are judged as healthy by self-reported health questionnaire 2. Subjects who agree to participate in this study with a written informed consent after receiving sufficient explanation relating to this study

Exclusion criteria

Exclusion criteria: 1. Subjects who have respiratory, gastrointestinal, hepatic/gallbladder/pancreatic, hematologic, renal, endocrine, cardiovascular and/or mental disease 2. Subjects who had a serious injury or surgical history within 12 weeks prior to this study 3. Pre- or post-menopausal women having obvious changes in physical condition 4. Subjects donate either 400ml or 200ml whole blood or blood component within four weeks prior to this study 5. Subjects who are pregnant or lactating, or subjects who expect to be pregnant during this study 6. Subjects who have cognitive disorder or who have possibility of the disorder 7. Subjects who participated and took the study drug in other clinical trials within four weeks prior to this study 8. Subjects who are judges as unsuitable for this study by the principal investigator or subinvestigators

Design outcomes

Primary

Measure	Time frame
Measurability in blood samples	—

Secondary

Measure	Time frame
1. Correlation between electrical conductivity (viscosity) of whole blood and plasma 2. Correlation between electrical conductivity (viscosity) of whole blood or plasma and whole blood viscosity 3. Correlation between electrical conductivity (viscosity) of whole blood or plasma and blood test values such as glycolipid levels 4. Correlation between electrical conductivity (viscosity) of whole blood or plasma and AGEs score 5. Correlation between electrical conductivity (viscosity) of whole blood or plasma and body measurements 6. Adverse events	—

Measure

Time frame

1. Correlation between electrical conductivity (viscosity) of whole blood and plasma 2. Correlation between electrical conductivity (viscosity) of whole blood or plasma and whole blood viscosity 3. Correlation between electrical conductivity (viscosity) of whole blood or plasma and blood test values such as glycolipid levels 4. Correlation between electrical conductivity (viscosity) of whole blood or plasma and AGEs score 5. Correlation between electrical conductivity (viscosity) of whole blood or plasma and body measurements 6. Adverse events

—

Countries

Japan

Contacts

Public ContactYasuji Arimura

University of Miyazaki Health-Care Research Department, University of Miyazaki

yasuji_arimura@med.miyazaki-u.ac.jp0985-85-9577

Outcome results